Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT03992261
- Locations
- 🇵🇱
Investigative Site 3, Krakow, Poland
🇵🇱Investigative Site 5, Tarnów, Poland
🇬🇪Investigative Site 10, Tbilisi, Georgia
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
- Conditions
- Interventions
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 65
- Registration Number
- NCT03738800
- Locations
- 🇺🇦
Medical Center of Private Enterprise "Dzerkalo", Dnipro, Ukraine
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Yale University, New Haven, Connecticut, United States
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
- Conditions
- Interventions
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 296
- Registration Number
- NCT03337490
- Locations
- 🇺🇸
Site 105, Dinuba, California, United States
🇺🇸Site 104, Miami, Florida, United States
🇺🇸Site 101, Plantation, Florida, United States
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
- First Posted Date
- 2016-12-01
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 140
- Registration Number
- NCT02978508
- Locations
- 🇺🇸
Southcoast Research Center, Miami, Florida, United States
🇺🇸LCC Medical Research Institute, Miami, Florida, United States
🇺🇸Mid Columbia Research, Richland, Washington, United States
Bioavailability Study of Lozanocâ„¢ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT02755857
- Locations
- 🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg
- First Posted Date
- 2015-12-04
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT02621905
- Locations
- 🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
- First Posted Date
- 2012-04-23
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01582932
- Locations
- 🇺🇸
Investigational Site, Tacoma, Washington, United States
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Mayne Pharma International Pty Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT01563068
- Locations
- 🇺🇸
Investigational Site, Houston, Texas, United States